Article Details
Retrieved on: 2024-06-22 23:02:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The treatment, called T-cell engager technology, uses the immune system's T-cells to attack and kill the cancer cell. The FDA approved a new T ...
Article found on: newpittsburghcourier.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here